About the lab

In the Marshall Lab, we’re interested in the epigenetic make-up of neural cell populations within the brain, and how chromatin and transcription affect brain development, disease and ageing.

We aim to understand how neural stem cells, neurons and glia change or maintain their fate, and how we can target epigenetic states to improve outcomes for Alzheimer’s disease and glioblastoma brain cancer.

As well as looking at these problems from a classic transcription and chromatin perspective, our research has also pushed us towards unexpected areas such as metabolism and ER stress – and how epigenetic changes regulate, and are regulated by, these processes.

Why do we care so much about chromatin?

Chromatin is what makes each of our different cell types distinct, with different functions. Without chromatin, we wouldn’t be us – we’d just be an amorphous mass of cells.

Within a cell, the activation of genes depends ultimately on their epigenetic environment. DNA is wrapped around nucleosomes to form chromatin, which can either be opened up to allow transcription factors to bind and genes to be transcribed, or condensed to shut down gene expression. Different forms of chromatin are regulated through combinations of chromatin-modifying proteins and the epigenetic histone modification marks that these proteins read or write. Together, these combinations of histone marks and chromatin proteins create what have been termed “chromatin states”.

Cell fate is predominantly controlled by regulating these transitions between open and closed chromatin states. But how that happens, what the principle forms of chromatin actually are, and which chromatin states are important for controlling gene expression in the brain, remain largely unknown.

We use the vinegar fly Drosophila melanogaster as a powerful model organism with which to study both chromatin and the brain, and answer these questions.

Wait, what? … you research the brain using flies?

We do indeed. Fly brains are remarkably similar to ours. They use many of the same neuronal transmitters as we do, and share many of the same types of neurons and the same types of glia (the neuronal support cells and in the brain). Their brains and ours share analogous structures, including a lobed structure of cholinergic neurons called the mushroom body, that stores and retrieves memories very similarly to our own lobed structure of cholinergic neurons: the hippocampus.

But above all, Drosophila come with an amazing genetic toolbox. In flies, you can manipulate gene expression and chromatin biology in ways that you couldn’t dream of doing in a mammalian model. We can turn on disease models selectively in individual cell types, where and when we want, and we can perform high-throughput oral drug screening in 48-well plates.

Furthermore, Drosophila have short lifespans. A happy, well-cared for vinegar fly will live for 60-80 days; a fly with modelled Alzheimer’s disease survives only 25 days. That makes them an ageing or neurodegenerative disease researcher’s new best friend, because ageing happens so much faster.

Phenomenal cosmic powers, itty-bitty living space

In the Marshall Lab, we combine all of this with cutting-edge genomic profiling tools such as Targeted DamID (TaDa). Using TaDa and other techniques, we can profile both the transcriptome and genome-wide chromatin states of individual subtypes of cells within the brain with extraordinarily fine temporal and spatial control.

We can also discover exactly where key transcription factors bind in individual cell types. With cell-type specific transcriptome, chromatin and transcription factor data, we’re now beginning to map out the gene regulatory networks that control cell fate and disease within the brain.